NASDAQ:GWPH

Delisted

GW Pharmaceuticals Plc Stock News

NASDAQ Stock Exchange

Open Broker Account

$218.96

+0 (+0%)

At Close: May 27, 2022

Evogene: Hidden Gems Of Computational Predictive Biology: (Part 4 Of 4), Canonic Ltd. (Medical Cannabis) (NASDAQ:EVGN)

06:30pm, Wednesday, 23'rd Sep 2020

Despite its recent share price increase, Evogene continues to be undervalued given the sum of parts valuation of its 4 main subsidiaries and $45 million cash position.

GW Pharmaceuticals: Buy the Dip? | The Motley Fool

12:00pm, Wednesday, 23'rd Sep 2020

The stock has fallen more than 20% in just the past three months.

The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma

12:00am, Wednesday, 23'rd Sep 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Arena Pharmaceuticals, Inc...

GW Pharmaceuticals PLC- (NASDAQ:GWPH) Position Reduced by Advisor Group Holdings Inc.

08:00am, Thursday, 17'th Sep 2020

Advisor Group Holdings Inc. cut its position in shares of GW Pharmaceuticals PLC- (NASDAQ:GWPH) by 37.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange

GW Pharmaceuticals PLC- (NASDAQ:GWPH) Shares Sold by Bank of America Corp DE

07:33am, Wednesday, 16'th Sep 2020

Bank of America Corp DE trimmed its holdings in GW Pharmaceuticals PLC- (NASDAQ:GWPH) by 23.9% during the second quarter, Holdings Channel reports. The institutional investor owned 360,760 shares of t

GW Pharmaceuticals plc (GWPH) CEO Justin Gover Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)

11:52pm, Tuesday, 15'th Sep 2020

GW Pharmaceuticals plc (NASDAQ:GWPH) Morgan Stanley 18th Annual Global Healthcare Conference September 15, 2020 4:15 PM ET Company Participants Justin Gover - Chief Executive Officer Darren Cline - Ch

Stifel Financial Corp Has $5.45 Million Stock Holdings in GW Pharmaceuticals PLC- (NASDAQ:GWPH)

06:20am, Tuesday, 15'th Sep 2020

Stifel Financial Corp grew its holdings in shares of GW Pharmaceuticals PLC- (NASDAQ:GWPH) by 0.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange

Euro hits six-month high vs pound; US jobless claims worse than feared - as it happened

04:42pm, Thursday, 10'th Sep 2020

Rolling coverage of the latest economic and financial news, as ECB says the eurozone saw a strong rebound over the summer

3 Cannabis Stocks to Avoid Like the Plague in September | The Motley Fool

11:08am, Thursday, 10'th Sep 2020

Investors will want to preserve their hard-earned capital by staying away from these marijuana companies for now.

GW Pharmaceuticals PLC: A Billionaire Has Loaded up on this Pot Stock

11:31am, Tuesday, 08'th Sep 2020

Pot stocks aren't really the go-to choice for institutional investors, but with GW Pharmaceuticals PLC (NASDAQ:GWPH), things may be starting to change.

2 Cannabis Stocks You'll Regret Not Buying During This Market Correction | The Motley Fool

09:24am, Sunday, 06'th Sep 2020

Both have struggled over the past year, but there are reasons to expect their stocks could stage strong comebacks over the longer term.

Unpacking Terpenes & Cannabinoids (Podcast Transcript)

04:47am, Sunday, 30'th Aug 2020

Everyone agrees that cannabis in the 21st century is far different than cannabis of the past - much of that has to do with terpenes.

GW Pharmaceuticals: A Buy After Stock Price Decline

11:30am, Wednesday, 26'th Aug 2020

Q2 results lead to an unwarranted stock price fall caused partly by activist traders. Revenue stream of epidiolex for TSC starting in second half of the year.

Unpacking Terpenes & Cannabinoids (Podcast)

07:00am, Wednesday, 26'th Aug 2020